Abstract
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1111/bju.16570
Journal: BJU international | Publication Date: Dec 1, 2024 |
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.